Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sampson

Showing results (301-310 of 393) with videos related to

Pageof 40
Sort By:
Journal of Neuro-Oncology|May 6, 2010
Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastomaDavid A Reardon, James J Vredenburgh, Annick Desjardins, et al.
Plos One|March 26, 2013
Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in miceLuis A Sanchez-Perez, Bryan D Choi, Gary E Archer, et al.
Neurosurgery|March 25, 2011
Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humansJohn H Sampson, Martin Brady, Raghu Raghavan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastomaJames J Vredenburgh, Annick Desjardins, David A Reardon, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2013
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomideLuis Sanchez-Perez, Bryan D Choi, Elizabeth A Reap, et al.
Molecular Cancer Therapeutics|October 15, 2009
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiformeJohn H Sampson, Gary E Archer, Duane A Mitchell, et al.
Neuro-Oncology|December 15, 2007
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case studyAmy B Heimberger, Wei Sun, S Farzana Hussain, et al.
Neurosurgery|December 20, 2007
Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety resultsMichael A Vogelbaum, John H Sampson, Sandeep Kunwar, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 26, 2018
Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cellsAhmet F Atik, Carter M Suryadevara, Ryan M Schweller, et al.
AIDS (London, England)|March 28, 1998
A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDSC L Brosgart, T A Louis, D W Hillman, et al.
Pageof 40

Showing results (301-310 of 393) with videos related to

Sort By:
Pageof 40
Journal of Neuro-Oncology|May 6, 2010
Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastomaDavid A Reardon, James J Vredenburgh, Annick Desjardins, et al.
Plos One|March 26, 2013
Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in miceLuis A Sanchez-Perez, Bryan D Choi, Gary E Archer, et al.
Neurosurgery|March 25, 2011
Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humansJohn H Sampson, Martin Brady, Raghu Raghavan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastomaJames J Vredenburgh, Annick Desjardins, David A Reardon, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2013
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomideLuis Sanchez-Perez, Bryan D Choi, Elizabeth A Reap, et al.
Molecular Cancer Therapeutics|October 15, 2009
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiformeJohn H Sampson, Gary E Archer, Duane A Mitchell, et al.
Neuro-Oncology|December 15, 2007
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case studyAmy B Heimberger, Wei Sun, S Farzana Hussain, et al.
Neurosurgery|December 20, 2007
Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety resultsMichael A Vogelbaum, John H Sampson, Sandeep Kunwar, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 26, 2018
Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cellsAhmet F Atik, Carter M Suryadevara, Ryan M Schweller, et al.
AIDS (London, England)|March 28, 1998
A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDSC L Brosgart, T A Louis, D W Hillman, et al.
Pageof 40